These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38777808)

  • 1. E-cadherin expression and gene expression profiles in corticotroph pituitary neuroendocrine tumor subtypes.
    Kiseljak-Vassiliades K; Lipe K; Turin CG; Fishbein L; Costello JC; Kerr JM; Holmstoen TB; Youssef AS; Lillehei KO; Kleinschmidt-DeMasters BK; Wierman ME
    J Neuropathol Exp Neurol; 2024 Jun; 83(7):586-595. PubMed ID: 38777808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours.
    Øystese KAB; Casar-Borota O; Berg-Johnsen J; Berg JP; Bollerslev J
    Endocrine; 2022 Jun; 77(1):151-159. PubMed ID: 35674926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors.
    García-Martínez A; Sottile J; Sánchez-Tejada L; Fajardo C; Cámara R; Lamas C; Barberá VM; Picó A
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1272-1282. PubMed ID: 30423170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
    Amano T; Masumoto T; Watanabe D; Hoshiai S; Mori K; Sakamoto N; Kino H; Akutsu H; Nakajima T
    Jpn J Radiol; 2023 Sep; 41(9):938-946. PubMed ID: 37027094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours.
    Evang JA; Berg JP; Casar-Borota O; Lekva T; Kringen MK; Ramm-Pettersen J; Bollerslev J
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):811-8. PubMed ID: 21595730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different levels of various glucocorticoid-regulated genes in corticotroph adenomas.
    Evang JA; Bollerslev J; Casar-Borota O; Lekva T; Ramm-Pettersen J; Berg JP
    Endocrine; 2013 Aug; 44(1):220-7. PubMed ID: 23315031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.
    Lasolle H; Elsensohn MH; Wierinckx A; Alix E; Bonnefille C; Vasiljevic A; Cortet C; Decoudier B; Sturm N; Gaillard S; Ferrière A; Roy P; Jouanneau E; Bertolino P; Bardel C; Sanlaville D; Raverot G
    Acta Neuropathol Commun; 2020 Nov; 8(1):190. PubMed ID: 33168091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
    Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
    Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of mutations in protein deubiquitinases genes and
    Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical Therapies in Functioning Pituitary Neuroendocrine Tumors(PitNETs)].
    Nagamine T; Fukuda I
    No Shinkei Geka; 2023 Jul; 51(4):706-715. PubMed ID: 37491068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of silent corticotroph adenomas.
    Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
    Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly.
    Fougner SL; Casar-Borota O; Heck A; Berg JP; Bollerslev J
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):96-102. PubMed ID: 21722151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles.
    Cassarino MF; Ambrogio AG; Cassarino A; Terreni MR; Gentilini D; Sesta A; Cavagnini F; Losa M; Pecori Giraldi F
    J Neuroendocrinol; 2018 Sep; 30(9):e12628. PubMed ID: 29920815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
    Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L
    J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
    Asa SL; Mete O; Riddle ND; Perry A
    Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating Methylome and Transcriptome Signatures Expands the Molecular Classification of the Pituitary Tumors.
    Silva-Júnior RMPD; Bueno AC; Martins CS; Coelli-Lacchini F; Ozaki JGO; Almeida-E-Silva DC; Marrero-Gutiérrez J; Santos ACD; Garcia-Peral C; Machado HR; Santos MVD; Elias PL; Moreira AC; Colli LM; Vêncio RZN; Antonini SR; de Castro M
    J Clin Endocrinol Metab; 2023 May; 108(6):1452-1463. PubMed ID: 36504388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.